News | December 17, 2023
Biocon Biologics recognized as an Asia IP Elite for 2023
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
This acquisition marks Max Healthcare's entry into Lucknow
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Subscribe To Our Newsletter & Stay Updated
